Details

Autor(en) / Beteiligte

• Lundsgaard, Dorthe, Research Scientist, Project Manager, Novo Nordisk A/S, Maaloev, Denmark
• Frederiksen, Klaus Stensgaard, Senior Scientist, Novo Nordisk A/S, Bagsvaerd, Denmark
• Hansen, Lasse Tengbjerg, Clinical Scientist, Novo Nordisk A/S, Bagsvaerd, Denmark
• Skrumsager, Birte K., Senior Clinical Pharmacologist, Novo Nordisk A/S, Bagsvaerd, Denmark
• Mouritzen, Ulrik, International Medical Officer, Novo Nordisk A/S, Bagsvaerd, Denmark
• McArthur, Grant, Professor, Cancer Trials Australia, Peter MacCallum Cancer Centre, Melbourne, Australia
• Davis, Ian D., Professor, Cancer Trials Australia, Austin Hospital, Melbourne, Australia
• Skak, Kresten, Senior Scientist, Novo Nordisk A/S, Bagsvaerd, Denmark

Titel

Combined Pharmacodynamic and Transcriptome Profiling of Recombinant Human Interleukin-21 Responses in Patients with Stage IV Malignant Melanoma

Ist Teil von

• Clinical immunology (Orlando, Fla.), 2007-01, Vol.123, p.S160-S160

Ort / Verlag

Elsevier Inc

Erscheinungsjahr

2007

Quelle

Alma/SFX Local Collection